Results 281 to 290 of about 24,341 (292)
Some of the next articles are maybe not open access.
Atypical hemolytic uremic syndrome in the Tunisian population
International Urology and Nephrology, 2010Hemolytic uremic syndrome consists of a triad of acquired hemolytic anemia, thrombocytopenia and renal failure.Our objectives were to determine epidemiology, clinical and laboratory characteristics of patients with atypical hemolytic uremic syndrome (aHUS) to determine the relationship between the complement protein deficit and aHUS in the Tunisian ...
Pilar Sánchez-Corral+11 more
openaire +3 more sources
Refractory Atypical Hemolytic Uremic Syndrome
Blood, 2012Abstract Abstract 4635 Atypical hemolytic uremic syndrome is a rare but often lethal disease if not diagnosed and treated early. The mainstay of treatment has been plasma exchange, though eculizumab has recently been approved for treatment.
Rebecca Redman+2 more
openaire +2 more sources
Atypical hemolytic uremic syndrome: a clinical conundrum
Pediatric Nephrology, 2016Patients negative for Shiga toxin-producing E. coli (STEC) are categorized as having atypical hemolytic uremic syndrome (HUS) and are associated with an increased risk for complement mutations and poorer prognosis compared with typical HUS. However, STEC identification is limited by the natural history of HUS.The current study is aimed at identifying ...
Rossana Baracco+4 more
openaire +3 more sources
Posttransplant recurrence of atypical hemolytic uremic syndrome
Journal of Nephrology, 2012Hemolytic uremic syndrome (HUS) is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. It is usually secondary to infections by strains of Escherichia coli (STEC) that produce Shiga-like toxin. In about 10% of patients, no STEC infections are reported.
Marta Alberti+2 more
openaire +2 more sources
Atypical hemolytic uraemic syndrome
Medicina Clínica (English Edition), 2015The hemolytic uremic syndrome (HUS) is a clinical entity characterized by thrombocytopenia, non-immune hemolytic anemia and renal impairment. Kidney pathology shows thrombotic microangiopathy (TMA) with endothelial cell injury leading to thrombotic occlusion of arterioles and capillaries.
Miquel Blasco Pelicano+2 more
openaire +3 more sources
Eculizumab treatment of atypical hemolytic uremic syndrome
Expert Opinion on Orphan Drugs, 2012Introduction: This review focuses on the use of an orphan drug eculizumab (Soliris®; Alexion Pharmaceuticals Inc.), for the treatment of an extremely rare disease, atypical hemolytic uremic syndrome (aHUS). aHUS is associated with very high mortality and morbidity rates.
Lawrence Copelovitch+2 more
openaire +2 more sources
Systematic review of atypical hemolytic uremic syndrome biomarkers
Pediatric nephrology (Berlin, West), 2022R. Raina+10 more
semanticscholar +1 more source
Pediatric nephrology (Berlin, West), 2022
Raquel Medeiros de Souza+6 more
semanticscholar +1 more source
Raquel Medeiros de Souza+6 more
semanticscholar +1 more source